Streetbeat News

Regulatory

FHN

First Horizon has announced the results of its 2023 company-run stress test, demonstrating resilience and a strong capital position. The company's minimum common equity tier 1 capital ratio was 8.7%, reflecting an additional $4 billion of pre-tax loss absorption capacity beyond the required regulatory minimums. The company's loan portfolio stressed loss rate was 2.3%, below the Federal Reserve-published median CCAR-bank result.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 1:10 pm

UTEN

The August Personal Consumption Expenditure (PCE) Price Index report showed mixed results, with the headline PCE price index increasing to 3.5% year-on-year, matching forecasts. The core PCE price index, excluding energy and food items, dropped to 3.9% year-on-year. Personal income and spending both increased by 0.4% in August. The US Treasury 10 Year Note ETF (NYSE:UTEN) is down nearly 4% this month. Traders assign an 85% probability to the Fed maintaining interest rates steady in the upcoming November FOMC meeting.

Portfolio Pulse from Piero Cingari

September 29, 2023 | 1:09 pm

LGST

Semper Paratus Acquisition Corporation has regained compliance with certain Nasdaq listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:55 pm

SPY

Senator Dianne Feinstein has passed away at the age of 90, as reported by Fox News. The news may have implications on the SPY ETF due to potential political shifts.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:50 pm

BLK

BTCUSD

SPY

The SEC has delayed Bitcoin ETF proposals from Blackrock and Valkyrie. Elon Musk has been censored on his own app. S&P 500 and Nasdaq futures point to a strong open ahead of key inflation data. More than $7M has been bet on Howard Hughes. Nike, OPKO Health, and other big stocks are moving higher in Friday's pre-market session. Investor fear is easing as US stocks rise following economic reports. Robert Kiyosaki is back to loving Bitcoin, thanks to fear of CBDCs. Pepe Coin is outpacing Dogecoin and Shiba Inu with a 12% surge. Bitcoin, Ethereum, and Dogecoin spike as Valkyrie Funds secures SEC approval for ETH ETF futures.

Portfolio Pulse from Akanksha Bakshi

September 29, 2023 | 12:47 pm

SGML

Sigma Lithium Corporation (NASDAQ:SGML) has denied recent media reports that inaccurately described certain conditions established by the Brazilian Courts as an 'injunction' that could impede the company's future operations and its Phase 2 & 3 expansion. The company affirmed that its expansion plans are proceeding as planned. The Brazilian Courts authorized the transfer of two Exploration Sub-Plots by RIX Mineração S.A. to Sigma Brazil without cost. Any compensation due to RIX is an internal matter and does not impact Sigma Brazil or Sigma Lithium.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:42 pm

NB

NioCorp Developments Ltd has filed a non-timely 10-K with the SEC, anticipating a net loss attributable to the company for the fiscal year of $39.5M or $(1.32) per share.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:36 pm

NWL

The Securities and Exchange Commission (SEC) has charged Newell Brands Inc. and its former CEO, Michael Polk, with misleading investors about the company's core sales growth. The SEC found that in 2016 and 2017, Newell and Polk manipulated the company's publicly disclosed core sales growth, which did not align with the actual sales trends. Newell and Polk have agreed to settle the SEC charges and will pay civil penalties of $12.5 million and $110,000, respectively.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:35 pm

ICU

The FDA has granted Breakthrough Device Designation to SeaStar Medical's Selective Cytopheretic Device for Cardiorenal Syndrome. This designation will expedite the development and review process of the device, potentially leading to faster market entry.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:33 pm

NVOS

White Diamond Research has issued a report suggesting that Novo Integrated Sciences (NVOS) may be involved in a scam with a convicted Ponzi scheme criminal. The report questions NVOS's recent PR about a one billion dollar collateral transfer through Blacksheep Trust, a company chaired by John Paul Baron, who was previously imprisoned for a $3-million Ponzi scheme. White Diamond Research predicts a potential lawsuit from the SEC against NVOS.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:33 pm